"In the wake of a detected cyber-attack, we have isolated all data center services to take required preventive actions," said Dr Reddy in a statement.
On Thursday, Dr. Reddy's Labs stock was trading down by more than 3 percent after reports that its plants worldwide had been shut down due to a data breach.
According to reports, the laboratories' plants in India, Brazil, Russia, the United Kingdom, and the United States were impacted by the data breach. It has shut down all production units after a breach in the server.
The share price of Dr Reddy's Laboratories reportedly fell on the report of the data breach. The stock was trading 2.94 percent lower at Rs. 4,898.45.
The development comes days after the company received approvals for clinical trials of the Sputnik vaccine for COVID-19 in India.